mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.008 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.008 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
0.45 |
0.008 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.008 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.009 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.009 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |